English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsVijayadiagnosticcentre

    Jump to
    • Vijaya Diagnostic: Healthy show continues

      Vijaya Diagnostic: Healthy show continues

      The management reiterated its guidance of achieving a top-line growth of around 15 percent and maintaining the current margin profile in FY26.

    • Buy Vijaya Diagnostic; target of Rs 1150: Emkay Global Financial

      Buy Vijaya Diagnostic; target of Rs 1150: Emkay Global Financial

      Emkay Global Financial is bullish on Vijaya Diagnostic has recommended buy rating on the stock with a target price of Rs 1150 in its research report dated May 13, 2025.

    • Hold Vijaya Diagnostic Centre; target of Rs 815: ICICI Securities

      Hold Vijaya Diagnostic Centre; target of Rs 815: ICICI Securities

      ICICI Securities recommended hold rating on Vijaya Diagnostic Centre with a target price of Rs 815 in its research report dated August 07, 2024.

    • Vijaya Diagnostic Centre: Sustaining strong margin profile

      Vijaya Diagnostic Centre: Sustaining strong margin profile

      Prudent strategies are in place to expand in the eastern and western regions of the country.

    • Reduce Vijaya Diagnostic Centre; target of Rs 590: ICICI Securities

      Reduce Vijaya Diagnostic Centre; target of Rs 590: ICICI Securities

      ICICI Securities recommended reduce rating on Vijaya Diagnostic Centre with a target price of Rs 590 in its research report dated December 22, 2023.

    • Vijaya Diagnostics: Price stability adds to constructive take

      Vijaya Diagnostics: Price stability adds to constructive take

      We see Vijaya Diagnostics as a good proxy for regional health-care services consumption play

    • Discovery series: Is it time to start looking at this quality diagnostic service?

      Discovery series: Is it time to start looking at this quality diagnostic service?

      We expect an earnings CAGR in mid-teens in the medium term for VDC on the back of an expansion-led volume growth in the hinterland

    • Vijaya Diagnostic: What does this regional player offer amid industry consolidation?

      Vijaya Diagnostic: What does this regional player offer amid industry consolidation?

      Going forward, technology will be the differentiator, and Vijay Diagnostic's differentiated hub- and-spoke model calls for attention

    • Vijaya Diagnostic IPO: Can this regional player repeat the success of KIMS IPO?

      Vijaya Diagnostic IPO: Can this regional player repeat the success of KIMS IPO?

      The key strength of Vijaya Diagnostic lies in its heavy B2C mix – more than 90 per cent of business flows from individual customers. This ensures that the company has almost negligible receivables which helps it to maintain a negative working capital.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347